Tailwinds' Take: Medeiros is a great hire for CATS. His resume is impressive and his experience meshes very well with the future envisioned by the Company. We are entering a very exciting stage of growth at Catasys, not only...
We are initiating coverage today on INmune Bio (Nasdaq: INMB). According to the Company, INmune (INMB) is “Reprogramming the Innate Immune System for the Treatment of Diseases”. On the surface, this sounds like a fairly standard biotech tagline, but...
As we head into the home stretch of 2019 the market for microcap stocks seems to have turned around. This time last year it was decimation in my space. Twenty-nineteen was shaping up that way over the last three...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.